New targeted cancer drug enters human trials
NCT ID NCT07354711
Summary
This study is testing a new drug called 3H-10000 for people with advanced lung or stomach cancer that cannot be removed by surgery or has spread. The main goals are to find a safe dose and to see if the drug can shrink tumors. The study will enroll about 170 adults and is currently recruiting participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
Contact
Conditions
Explore the condition pages connected to this study.